Matrix Biomed And Apexbio
matrix protein (3-15) [Zaire ebolavirus] |
|||
A1080-1 | ApexBio | 1 mg | 129.6 EUR |
Description: Matrix protein (3-15) is a peptide of the structure proteins linking the viral envelope with theZaireebolavirus core.Ebola virus (EBOV) is a member of the familyFiloviridaein the orderMononegavirales. |
Apexbio Reagents Laboratories manufactures the matrix biomed and apexbio reagents distributed by Genprice. The Matrix Biomed And Apexbio reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Apexbio Reagents. Other Matrix products are available in stock. Specificity: Matrix Category: Biomed Group: And Apexbio
HDL and LDL/VLDL Quantification Colorimetric/Fluorometric Kit |
||
ApexBio | 100 assays | 835.2 EUR |
Total Cholesterol and Cholesteryl Ester Colorimetric Assay Kit II |
||
ApexBio | 100 assays | 634.8 EUR |
Total Cholesterol and Cholesteryl Ester Colorimetric/Fluorometric Assay Kit |
||
ApexBio | 100 assays | 652.8 EUR |
CX-5461 |
||
ApexBio | 50 mg | 811.2 EUR |
Description: CX-5461 is a potent and orally bioavailable small-molecule inhibitor of rRNA synthesis that specifically inhibits RNA polymerase (Pol) I-driven transcription with IC50 value of 142 nM. |
||
CX-5461 |
||
ApexBio | Evaluation Sample | 97.2 EUR |
Description: CX-5461 is a potent and orally bioavailable small-molecule inhibitor of rRNA synthesis that specifically inhibits RNA polymerase (Pol) I-driven transcription with IC50 value of 142 nM. |
||
NSC 74859 |
||
ApexBio | 10 mg | 157.2 EUR |
Description: S3I-201 is a selective inhibitor of Stat3 with IC50 value of 86 ?M [1].In the in vitro Stat3 DNA-binding assay, S3I-201 showed potent inhibition of the Stat3 DNA-binding activity with an average IC50 of 86 ?M. |
||
NSC 74859 |
||
ApexBio | 200 mg | 793.2 EUR |
Description: S3I-201 is a selective inhibitor of Stat3 with IC50 value of 86 ?M [1].In the in vitro Stat3 DNA-binding assay, S3I-201 showed potent inhibition of the Stat3 DNA-binding activity with an average IC50 of 86 ?M. |
SARS Matrix Peptide |
|||
3529P | ProSci | 0.05 mg | 197.7 EUR |
Description: (CT) SARS Matrix peptide |
|||
Bone Matrix Proteins |
|||
20-abx265965 | Abbexa |
|
|
MATRIX 1250UL TIP |
|||
MTX-1250-C | CORNING | 500/pk | 285.6 EUR |
Description: Non Filter Tips; Pipette Tips - Axygen |
|||
MATRIX 1250UL TIP |
|||
MTX-1250-C-R | CORNING | 1152/pk | 265.2 EUR |
Description: Non Filter Tips; Pipette Tips - Axygen |
|||
Matrix Tips 1250ul |
|||
MAT8042 | Scientific Laboratory Supplies | PK960 | 213.18 EUR |
Acids Matrix Spike |
|||
CLPS-MSA | Scientific Laboratory Supplies | 1ML | 120.84 EUR |
Cartilage Dissociation System 2 (Articular cartilage, Chondrocytes, Matrix vesicles, Wing buds), Mouse and Rat |
|||
4-20232 | CHI Scientific | ea | Ask for price |
Matrix protein Polyclonal Antibody |
|||
42629-100ul | SAB | 100ul | 399.6 EUR |
SARS-CoV Matrix Antibody |
|||
3527-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4). |
|||
SARS-CoV Matrix Antibody |
|||
3527-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4). |
|||
SARS-CoV Matrix Antibody |
|||
3529-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4). |
|||
SARS-CoV Matrix Antibody |
|||
3529-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1). SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2).The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4). |
|||
Influenza A antibody (Matrix) |
|||
20C-CR1235GP | Fitzgerald | 1 ml | 501.6 EUR |
Description: Goat polyclonal Influenza A antibody (Matrix) |
|||
Matrix Metalloproteinase-8 Enzyme |
|||
20-abx073423 | Abbexa |
|
|
Matrix Metalloproteinase-28 (Recombinant) |
|||
20-abx073425 | Abbexa |
|
|
Matrix Metallopeptidase 23B (Recombinant) |
|||
20-abx073584 | Abbexa |
|
|
Matrix Metalloproteinase-9 (Recombinant) |
|||
20-abx073656 | Abbexa |
|
|